Targeted drug delivery to the retinal pigment epithelium: Untapped therapeutic potential for retinal diseases

被引:15
作者
Bohley, Marilena [1 ]
Dillinger, Andrea E. [2 ]
Tamm, Ernst R. [2 ]
Goepferich, Achim [1 ]
机构
[1] Univ Regensburg, Dept Pharmaceut Technol, D-93053 Regensburg, Germany
[2] Univ Regensburg, Dept Human Anat & Embryol, D-93053 Regensburg, Germany
关键词
Retinal pigment epithelium; RPE; Retinal diseases; Retinopathy of prematurity; Diabetic retinopathy; Age-related macular degeneration; Targeted drug delivery; Nanotherapy; DIABETIC-RETINOPATHY; DNA NANOPARTICLES; GENE-EXPRESSION; BRUCHS MEMBRANE; GROWTH-FACTORS; RPE; EYE; SYSTEM; MECHANISMS; RECEPTORS;
D O I
10.1016/j.drudis.2022.05.024
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The retinal pigment epithelium (RPE) plays a crucial part in sight-threatening diseases. In this review, we shed light on the pivotal implication of the RPE in age-related macular degeneration, diabetic retinopathy and retinopa-thy of prematurity; and explain why a paradigm shift toward targeted RPE therapy is needed to efficiently fight these retinal diseases. We provide guidance for the devel-opment of RPE-specific nanotherapeutics by giving a comprehensive overview of the possibilities and challenges of drug delivery to the RPE and highlight successful nanotherapeutic approaches targeting the RPE.
引用
收藏
页码:2497 / 2509
页数:13
相关论文
共 112 条
  • [41] Intravitreal nanoparticles for retinal delivery
    Huang, Xiaonan
    Chau, Ying
    [J]. DRUG DISCOVERY TODAY, 2019, 24 (08) : 1510 - 1523
  • [42] Topical and systemic drug delivery to the posterior segments
    Hughes, PM
    Olejnik, O
    Chang-Lin, JE
    Wilson, CG
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2005, 57 (14) : 2010 - 2032
  • [43] Medical progress: Age-related macular degeneration
    Jager, Rama D.
    Mieler, William F.
    Miller, Joan W.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (24) : 2606 - 2617
  • [44] Progress on ocular siRNA gene-silencing therapy and drug delivery systems
    Jiang, Jinjin
    Zhang, Xinru
    Tang, Yue
    Li, Shuhan
    Chen, Jing
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2021, 35 (01) : 4 - 24
  • [45] Complement activation and inflammatory processes in drusen formation and age related macular degeneration
    Johnson, LV
    Leitner, WP
    Staples, MK
    Anderson, DH
    [J]. EXPERIMENTAL EYE RESEARCH, 2001, 73 (06) : 887 - 896
  • [46] Systemic dendrimer nanotherapies for targeted suppression of choroidal inflammation and neovascularization in age-related macular degeneration
    Kambhampati, Siva P.
    Bhutto, Imran A.
    Wu, Tony
    Ho, Katie
    McLeod, D. Scott
    Lutty, Gerard A.
    Kannan, Rangaramanujam M.
    [J]. JOURNAL OF CONTROLLED RELEASE, 2021, 335 : 527 - 540
  • [47] Systemic and Intravitreal Delivery of Dendrimers to Activated Microglia/Macrophage in Ischemia/Reperfusion Mouse Retina
    Kambhampati, Siva P.
    Clunies-Ross, Alexander J. M.
    Bhutto, Imran
    Mishra, Manoj K.
    Edwards, Malia
    McLeod, D. Scott
    Kannan, Rangaramanujam M.
    Lutty, Gerard
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (08) : 4413 - 4424
  • [48] Nanotherapy for posterior eye diseases
    Kaur, Indu Pal
    Kakkar, Shilpa
    [J]. JOURNAL OF CONTROLLED RELEASE, 2014, 193 : 100 - 112
  • [49] Directional protein secretion by the retinal pigment epithelium: roles in retinal health and the development of age-related macular degeneration
    Kay, Paul
    Yang, Yit C.
    Paraoan, Luminita
    [J]. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2013, 17 (07) : 833 - 843
  • [50] DNA nanoparticles are safe and nontoxic in non-human primate eyes
    Kelley, Ryan A.
    Conley, Shannon M.
    Makkia, Rasha
    Watson, Jamie N.
    Han, Zongchao
    Cooper, Mark J.
    Naash, Muna I.
    [J]. INTERNATIONAL JOURNAL OF NANOMEDICINE, 2018, 13 : 1361 - 1379